ELOCTA

UNIVADIS - ELOCTA /univadis/ELOCTA.md

ATC

Μορφές: PS.INJ.SOL

Ημερομηνία	barcode	code	περιεχομενο	τιμή παραγωγός	χονδρική	λιανική
05/2018	2803139601012	313960101	ELOCTA PS.INJ.SOL 250IU/VIAL BTx1 VIAL (γυάλινο) + 1 PF SYR (γυάλινη) x 3 ML SOLV	173.65	182.16	220.12
05/2018	2803139602019	313960201	ELOCTA PS.INJ.SOL 500IU/VIAL BTx1 VIAL (γυάλινο) + 1 PF SYR (γυάλινη) x 3 ML SOLV	347.29	352.51	411.03
05/2018	2803139603016	313960301	ELOCTA PS.INJ.SOL 750IU/VIAL BTx1 VIAL (γυάλινο) + 1 PF SYR (γυάλινη) x 3 ML SOLV	585.90	594.70	680.82
05/2018	2803139604013	313960401	ELOCTA PS.INJ.SOL 1000IU/VIAL BTx1 VIAL (γυάλινο) + 1 PF SYR (γυάλινη) x 3 ML SOLV	694.59	705.02	795.90
05/2018	2803139605010	313960501	ELOCTA PS.INJ.SOL 1500IU/VIAL BTx1 VIAL (γυάλινο) + 1 PF SYR (γυάλινη) x 3 ML SOLV	1041.89	1057.54	1177.05
05/2018	2803139606017	313960601	ELOCTA PS.INJ.SOL 2000IU/VIAL BTx1 VIAL (γυάλινο) + 1 PF SYR (γυάλινη) x 3 ML SOLV	1389.17	1410.04	1558.17
05/2018	2803139607014	313960701	ELOCTA PS.INJ.SOL 3000IU/VIAL BTx1 VIAL (γυάλινο) + 1 PF SYR (γυάλινη) x 3 ML SOLV	2083.77	2115.07	2309.23

DRUGBANK - Antihemophilic Factor
indication:
For the treatment of hemophilia A, von Willebrand diseae and Factor XIII deficiency
pharmacology:
mechanism:
Antihemophilic factor (AHF) is a protein found in normal plasma which is necessary for clot formation. The administration of AHF provides an increase in plasma levels of AHF and can temporarily correct the coagulation defect of patients with hemophilia A (classical hemophilia).
toxicity:
absorprion:
halflife:
8.4-19.3 hrs
roouteelimination:
volumedistribution:
clearance:
* 4.1 mL/h•kg [Previously treated pediatric patients]